The global neurovascular devices market is expected to grow at a CAGR of 10.3% in the first half of the forecast period. In 2016, the Cerebral Embolization and Aneurysm Coiling Devices segment held the largest share in the global neurovascular devices market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 152-page report you will receive 85 charts– all unavailable elsewhere.
The 152-page report provides clear detailed insight into the global neurovascular devices market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Neurovascular Devices market forecasts to 2027
• This report also breaks down the revenue forecast for the global neurovascular market by submarket
– Cerebral Embolization and Aneurysm Coiling Devices
– Cerebral Angioplasty and Stenting Systems
– Support Devices
– Neurothrombectomy Devices
• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– The US
– EU5: Germany, France, the UK, Italy, Spain
– Japan
– BRIC: Brazil, Russia, India, China
– Rest of the World (RoW)
• Our study gives qualitative analysis of the neurovascular devices market. It discusses the SWOT analysis of the neurovascular devices market.
• Our study discusses the selected leading companies that are the major players in the neurovascular devices industry:
– Stryker Corporation
– Medtronic
– Johnson & Johnson
– Terumo
– Penumbra
Visiongain’s study is intended for anyone requiring commercial analyses for the global b neurovascular devices market. You find data, trends and predictions.
Buy our report today Global Neurovascular Devices Market Forecast to 2027: Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Global Neurovascular Devices Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Neurovascular Diseases
2.1 Overview
2.2 Stroke
2.2.1 Types of Strokes
2.2.1.1 Ischaemic stroke:
2.2.1.2 Haemorrhagic stroke:
2.3 Cerebral Artery Stenosis
2.3.1 Diagnosis
2.3.2 Treatment of Cerebral Artery Stenosis
2.3.2.1 Angioplasty
2.3.2.2 Cerebral artery bypass
2.4 Cerebral Aneurysm
2.4.1 Causes of Cerebral Aneurysm
2.4.2 Types of Aneurysms
2.4.3 Prevalence of Aneurysms
2.4.4 Diagnosis of Aneurysms
2.4.5 Treatment of Aneurysms
2.5 Arteriovenous Malformation and Fistulas
2.5.1 Types of AVMs
2.5.2 Epidemiology
2.5.3 Diagnosis of AVM
2.5.4 Treatment of AVMs
3. Global Neurovascular Devices Market Forecast to 2027
3.1 The Global Neurovascular Devices Market Forecast to 2027
4. Leading Neurovascular Devices Submarket Forecast to 2027
4.1 Devices Composition of the Global Market in 2016 and 2027
4.2 Leading Devices Markets for Neurovascular Devices Forecast to 2027
4.2.1 Cerebral Embolization and Aneurysm Coiling Devices
4.2.1.1 Cerebral Embolization and Aneurysm Coiling Devices Market Forecast to 2027
4.2.2 Cerebral Angioplasty and Stenting Systems
4.2.2.1 Cerebral Angioplasty and Stenting Systems Market Forecast to 2027
4.2.3 Support Devices
4.2.3.1 Support Devices Market Forecast to 2027
4.2.4 Neurothrombectomy Devices
4.2.4.1 Neurothrombectomy Devices Market Forecast to 2027
5. Neurovascular Devices: Leading Regional and National Market Forecast to 2027
5.1 Regional Composition of the Global Market in 2016 and 2027
5.3 Leading Regional and National Markets for Neurovascular Devices Market Forecast to 2027
5.3.1 US Neurovascular Devices Market Forecast to 2027
5.3.1.1 The US Will Dominate Throughout the Forecast Period
5.3.1.2 US Neurovascular Devices Market Forecast to 2027
5.3.2 EU5 Neurovascular Devices Market Forecast to 2027
5.3.2.1 German Neurovascular Devices Market: Leader in EU, but Facing Big Reforms
5.3.2.1.1 German Neurovascular Devices Market Forecast to 2027
5.3.2.2 French Neurovascular Devices Market: Strong National Healthcare System, Despite Economic Woes
5.3.2.2.1 French Neurovascular Devices Market Forecast to 2027
5.3.2.3 Italian Neurovascular Devices Market
5.3.2.3.1 Italian Neurovascular Devices Market Forecast to 2027
5.3.2.4 UK Neurovascular Devices Market: Pricing is a Key Issue, Providing Restraints to Revenues
5.3.2.4.1 UK Neurovascular Devices Market Forecast to 2027
5.3.2.5 Spanish Neurovascular Devices Market
5.3.2.5.1 Spanish Neurovascular Devices Market Forecast to 2027
5.3.3 Japanese Neurovascular Devices Market
5.3.3.1 Japanese Neurovascular Devices Market Forecast to 2027
5.3.4 BRIC Neurovascular Devices Market Forecast to 2027
5.3.4.1 China Neurovascular Devices Market: Rapid Growth Will Make it one of the Major Global Players
5.3.4.1.1 China Neurovascular Devices Market Forecast to 2027
5.3.4.2 Brazilian Neurovascular Devices Market: Taken Great Strides Forward with Healthcare
5.3.4.2.1 Brazilian Neurovascular Devices Market Forecast to 2027
5.3.4.3 Russian Neurovascular Devices Market: Punches Below its Weight
5.3.4.3.1 Russian Neurovascular Devices Market Forecast to 2027
5.3.4.4 Indian Neurovascular Devices Market
5.3.4.4.1 Indian Neurovascular Devices Market Forecast to 2027
5.3.5 Rest of the World (ROW)
5.3.5.1 ROW Neurovascular Devices Market Forecast, 2016-2027
6. SWOT Analysis of the Neurovascular Devices Market
6.1 Strengths
6.1.1 Aging Population
6.1.2 Rising Incidence of Obesity
6.1.3 High Incidence of Strokes
6.1.4 Increasing Demand for Minimally Invasive Procedures
6.1.5 Technological Advancements
6.2 Weakness
6.2.1 Disadvantages of Neurovascular Devices
6.3 Opportunities
6.3.1 Healthcare expenditures
6.4 Threats
6.4.1 High Cost of R&D Activities
7. Leading Companies
7.1 Stryker Corporation
7.1.1 Introduction
7.1.2 Recent Performance Analysis
7.1.3 Total Company Sales by Business Segments,2016
7.1.4 Stryker Products
7.2 Medtronic
7.2.1 Introduction
7.2.2 Recent Performance Analysis
7.2.3 Total Company Sales by Business Segments,2017
7.2.4 Medtronic Products
7.3 Johnson & Johnson
7.3.1 Introduction
7.3.2 Recent Performance Analysis
7.3.3 Total Company Sales by Business Segments,2016
7.3.4 Johnson & Johnson Products
7.4 Terumo
7.4.1 Introduction
7.4.2 Recent Performance Analysis
7.4.3 Total Company Sales by Business Segments,2016
7.4.4 Terumo Products
7.5 Penumbra
7.5.1 Introduction
7.5.2 Recent Performance Analysis
7.5.3 Total Company Sales by Business Segments,2016
7.5.4 Penumbra Products
8. Conclusion
8.1 Neurovascular Devices Market Forecast
8.2 The US has the Largest Share
8.3 Cerebral Embolization and Aneurysm Coiling Devices Dominates the Neurovascular Devices Market
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Figures
Figure 3.1 Global Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 4.1 Devices Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2016
Figure 4.2 Devices Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2027
Figure 4.3 Devices Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), 2016-2027
Figure 4.4 Cerebral Embolization and Aneurysm Coiling Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 4.5 Cerebral Angioplasty and Stenting Systems Market Forecast: Revenues ($bn), 2016-2027
Figure 4.6 Support Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 4.7 Neurothrombectomy Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.1 Regional Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2016
Figure 5.2 Regional Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2027
Figure 5.3 Regional Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), 2016-2027
Figure 5.4 US Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.5 German Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.6 French Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.7 Italian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.8 UK Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.9 Spanish Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.10 Japanese Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.11 Chinese Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.12 Brazilian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.13 Russian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.14 Indian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 5.15 ROW Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
Figure 6.1 Stryker: Sales by Business Segments, 2016
Figure 6.2 Medtronic: Sales by Business Segments, 2017
Figure 6.3 Johnson & Johnson: Sales by Business Segments, 2016
Figure 6.4 Terumo: Sales by Business Segments, 2016
Figure 6.5 Penumbra: Sales by Business Segments, 2016
Figure 8.1 Global Neurovascular Devices Market by Region ($bn) (2016 and 2021)
Figure 8.2 Global Neurovascular Devices Market by Region ($bn) (2022 and 2027)
Figure 8.3 Global Neurovascular Devices Market by Device Type ($bn) (2016, 2022, 2027)
List of Tables
Table 3.1 Global Neurovascular Devices Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2016-2021
Table 3.2 Global Neurovascular Devices Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2022-2027
Table 4.1 Devices Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 4.2 Devices Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 4.3 Cerebral Embolization and Aneurysm Coiling Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 4.4 Cerebral Embolization and Aneurysm Coiling Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 4.5 Cerebral Angioplasty and Stenting Systems Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 4.6 Cerebral Angioplasty and Stenting Systems Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 4.7 Support Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 4.8 Support Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 4.9 Neurothrombectomy Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 4.10 Neurothrombectomy Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.1 Regional Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.2 Regional Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.3 US Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.4 US Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.5 German Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.6 German Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.7 French Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.8 French Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.9 Italian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.10 Italian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.11 UK Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.12 UK Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.13 Spanish Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.14 Spanish Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.15 Japanese Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.16 Japanese Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.17 Chinese Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.18 Chinese Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.19 Brazilian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.20 Brazilian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.21 Russian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.22 Russian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.23 Indian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.24 Indian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 5.25 ROW Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
Table 5.26 ROW Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
Table 6.1 Global Neurovascular Devices Market SWOT Analysis 2016-2027
Table 6.2 Healthcare Expenditure (% of GDP)
Table 7.1 Stryker: Sales and Market shares by Business Segments, 2016
Table 7.2 Stryker Products
Table 7.3 Medtronic: Sales and Market shares by Business Segments, 2017
Table 7.4 Medtronic Products
Table 7.5 Johnson & Johnson: Sales and Market shares by Business Segments, 2016
Table 7.6 Johnson & Johnson Products
Table 7.7 Terumo: Sales and Market shares by Business Segments, 2016
Table 7.8 Terumo Products
Table 7.9 Penumbra: Sales and Market shares by Business Segments, 2016
Table 7.10 Penumbra Products
Table 8.1 Global Neurovascular Devices Market Forecast ($m) (2016, 2021, 2027)
Table 8.2 Global Neurovascular Devices Market by Region ($bn) (2016 and 2021)
Table 8.3 Global Neurovascular Devices Market by Region ($bn) (2022 and 2027)
Table 8.4 Global Neurovascular Devices Market by Device Type ($bn) (2016, 2022, 2027)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
